跳至主要内容
临床试验/DRKS00033035
DRKS00033035招募中不适用

Association of end-stage renal disease with the prognosis and hemostasis of patients with atrial flimmern or coronary heart disease - HERACles

niversitätsklinikum Freiburg0 个研究点目标入组 238 人开始时间: 2024年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
238

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients over 18 years old with chronic kidney insufficiency from stage IV according to KDIGO
  • known atrial fibrillation and/or coronary heart disease
  • Stable kidney retention parameters
  • consistent administration of anticoagulants/platelet aggregation inhibitors and no medication change for at least 1 week, or no anticoagulants/platelet aggregation inhibitors due to high bleeding risk.

排除标准

  • Patients with known coagulation disorders, liver insufficiency, or active cancer disease
  • Acute kidney failure in the current hospital stay
  • Severe thrombocytopenia (< 100,000/µl) or thrombocytosis (> 450,000/µl)
  • Noncompliance, lack of consistent medication intake

研究者

相似试验

Association of end-stage renal disease with the... | 临床试验